Impact of Apo E gene polymorphism on HCV therapy related outcome in a cohort of HCV Egyptian patients

The functional apolipoprotein E (Apo E) gene polymorphism could be used as a determinant of outcome of HCV infection. This study aimed to demonstrate the impact of Apo E genotype on the response to HCV combined therapy. Material and methods: The study has been implemented on 125 individuals with per...

Full description

Bibliographic Details
Main Authors: Howayda E. Gomaa, Mohamed Mahmoud, Nevine E. Saad, Amal Saad-Hussein, Somaia Ismail, Eman H. Thabet, Hebatallah Farouk, Dina Kandil, Ahmed Heiba, Wael Hafez
Format: Article
Language:English
Published: SpringerOpen 2018-06-01
Series:Journal of Genetic Engineering and Biotechnology
Online Access:http://www.sciencedirect.com/science/article/pii/S1687157X1730080X